The coronavirus disease 2019 (COVID-19) pandemic underscored the need for the development of tools that can visualize immune system activity in the context of viral inflammation. Although [18F]FDG PET ...
Leucine-rich repeat–containing protein 15 (LRRC15) is a cell surface protein that has emerged as a significant biomarker in cancer biology. This protein is minimally expressed in normal healthy tissue ...
High expression of prostate-specific membrane antigen (PSMA) is not limited to prostate cancer but can be found in other tumor entities, such as hepatocellular carcinoma (HCC), and could possibly be ...
Dr. Bernd Pichler is a distinguished pioneer in preclinical and translational imaging, renowned for his groundbreaking work ...
Journal of Nuclear Medicine October 2025, jnumed.125.271028; DOI: https://doi.org/10.2967/jnumed.125.271028 ...
Journal of Nuclear Medicine September 2025, jnumed.125.270267; DOI: https://doi.org/10.2967/jnumed.125.270267 ...
Journal of Nuclear Medicine August 2025, jnumed.124.269234; DOI: https://doi.org/10.2967/jnumed.124.269234 ...
Journal of Nuclear Medicine August 2025, jnumed.124.268841; DOI: https://doi.org/10.2967/jnumed.124.268841 ...
Journal of Nuclear Medicine June 2025, jnumed.124.269273; DOI: https://doi.org/10.2967/jnumed.124.269273 ...
Radioimmunotherapy using 225Ac, a highly cytotoxic α-particle emitter, has potential for treating advanced breast cancer, especially human epidermal growth factor receptor 2 (HER2)–positive cases. We ...
Journal of Nuclear Medicine June 2025, 66 (supplement 1) 252173; ...
Nuclear medicine has evolved from a diagnostic-oriented speciality toward theranostics. Radionuclide therapy has become a booming business with newer radiopharmaceuticals and indications. Although the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback